trending Market Intelligence /marketintelligence/en/news-insights/trending/hbzx5xk-xkjpu02h2pxh1g2 content esgSubNav
In This List

QRxPharma adds director to board

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


QRxPharma adds director to board

QRxPharma Ltd. appointed Anthony Jefferies to its board.

Jefferies is a partner at Gillis Delaney Lawyers.

Australia's QRxPharma develops pain medications.